您当前所在位置:首页 > 资讯信息 > 新品上市
CAS: 302941-52-2 DUPA 化合物DUPA
发布时间:2024-04-28     作者:kx   分享到:

产品描述:

DUPA (N,N''-Carbonylbis[L-glutamic acid]) is used as the targeting moiety to actively deliver DTX for treatment of Prostate-Specific Membrane Antigen (PSMA) expressing prostate cancer.

体外活性 DUPA is used as the targeting moiety to actively deliver Docetaxel (DTX) for treatment of prostate-specific membrane antigen (PSMA) expressing prostate cancer.

体内活性 As determined by loss of body weight and death of treated mice,DUPA-indenoisoquinoline conjugate induces a complete cessation of tumor growth with no toxicity[2].

别名 N,N''-Carbonylbis[L-glutamic acid], (2S,2'S)-2,2'-Carbonylbis(Azanediyl)Dipentanedioic Acid

分子量 320.25

分子式 C11H16N2O9

CAS No. 302941-52-2

存储

Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度

DMSO: 280 mg/mL (874.32 mM)

H2O: 140 mg/mL (437.16 mM)

CAS:	302941-52-2	DUPA	化合物DUPA

PROteolysis TArgeting Chimeras (PROTACs) 通过将靶蛋白和 E3 连接酶结合起来,从而“劫持”细胞的泛素-蛋白酶体系统(UPS)来实现蛋白质的降解。由于 PROTACs 只需具有高选择性地结合其靶标(而不是抑制靶蛋白的酶活性),目前有许多努力将先前无效的抑制剂分子改造为 PROTACs,用作下一代药物。

产地:西安

用途:科研!

厂家:西安齐岳生物科技有限公司

温馨提示:仅用于科研,不能用于人体实验!

相关产品:  

PROTAC EGFR degrader 4

PROTAC CDK9 degrader-2

SZUH280

Nrf2 degrader 1 

KRAS degrader-1

NU223612

JH-XII-03-02


库存查询